Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
April 17, 2024 13:51 ET
|
Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
Sustain SoCal Announces Building Sustainable Communities
March 20, 2024 09:35 ET
|
Sustain SoCal
NEWPORT BEACH, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- via InvestorWire -- Sustain Southern California (“Sustain SoCal”) is proud to host the Building Sustainable Communities conference to be...
Denny’s Canada tickles guests pink with their $4.99 Grand Slam breakfast in support of Pink Shirt Day
March 01, 2024 12:00 ET
|
Denny's Canada
VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- On Tuesday 27th of February, in 60 participating locations across Canada, Denny’s once again partnered with the WITS Programs...
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
NFWF’s Chi-Cal Rivers Fund Announces $1.85 Million in Grants
December 12, 2023 10:00 ET
|
National Fish and Wildlife Foundation
CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The Chi-Cal Rivers Fund partners today announced $1.85 million in grants to improve and enhance waterways in the Chicago-Calumet region. These investments...
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
November 13, 2023 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
November 09, 2023 16:00 ET
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023 08:00 ET
|
aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...
TRUE Announces Strategic Investment Round to Scale NFT Engagement Tools for Brands
August 01, 2023 20:48 ET
|
TRUE
Lisbon, Portugal, Aug. 01, 2023 (GLOBE NEWSWIRE) -- TRUE, a leading platform providing white-label NFT solutions and engagement tools for Web2 businesses, initiates the launch of its strategic...